RUIWEN ZHANG's research topics

RUIWEN ZHANG

Concepts (24)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with RUIWEN ZHANG's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that RUIWEN ZHANG has written about over time.

Apoptosis, 1 publications between 2018 and 2018, average publication date September 2018. Calcineurin, 1 publications between 2018 and 2018, average publication date September 2018. Cell Line, Tumor, 1 publications between 2018 and 2018, average publication date September 2018. Deoxycytidine, 1 publications between 2018 and 2018, average publication date September 2018. Drug Discovery, 1 publications between 2018 and 2018, average publication date September 2018. Drug Screening Assays, Antitumor, 1 publications between 2018 and 2018, average publication date September 2018. Gene Expression Regulation, Neoplastic, 1 publications between 2018 and 2018, average publication date September 2018. Heterocyclic Compounds, 3-Ring, 1 publications between 2018 and 2018, average publication date September 2018. Mice, Nude, 1 publications between 2018 and 2018, average publication date September 2018. Neoplasm Transplantation, 1 publications between 2018 and 2018, average publication date September 2018. NFATC Transcription Factors, 1 publications between 2018 and 2018, average publication date September 2018. Pancreatic Neoplasms, 1 publications between 2018 and 2018, average publication date September 2018. Protein Binding, 1 publications between 2018 and 2018, average publication date September 2018. RNA, Small Interfering, 1 publications between 2018 and 2018, average publication date September 2018. Tumor Suppressor Protein p53, 1 publications between 2018 and 2018, average publication date September 2018. Antineoplastic Agents, 2 publications between 2018 and 2024, average publication date July 2021. Proto-Oncogene Proteins c-mdm2, 2 publications between 2018 and 2024, average publication date July 2021. Molecular Targeted Therapy, 1 publications between 2024 and 2024, average publication date April 2024. Neoplasms, 1 publications between 2024 and 2024, average publication date April 2024.

Apoptosis
Calcineurin
Cell Line, Tumor
Deoxycytidine
Drug Discovery
Drug Screening Assays, Antitumor
Gene Expression Regulation, Neoplastic
Heterocyclic Compounds, 3-Ring
Mice, Nude
Neoplasm Transplantation
NFATC Transcription Factors
Pancreatic Neoplasms
Protein Binding
RNA, Small Interfering
Tumor Suppressor Protein p53
Antineoplastic Agents
Proto-Oncogene Proteins c-mdm2
Molecular Targeted Therapy
Neoplasms

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Apoptosis	1	2018	2018	September 2018
Calcineurin	1	2018	2018	September 2018
Cell Line, Tumor	1	2018	2018	September 2018
Deoxycytidine	1	2018	2018	September 2018
Drug Discovery	1	2018	2018	September 2018
Drug Screening Assays, Antitumor	1	2018	2018	September 2018
Gene Expression Regulation, Neoplastic	1	2018	2018	September 2018
Heterocyclic Compounds, 3-Ring	1	2018	2018	September 2018
Mice, Nude	1	2018	2018	September 2018
Neoplasm Transplantation	1	2018	2018	September 2018
NFATC Transcription Factors	1	2018	2018	September 2018
Pancreatic Neoplasms	1	2018	2018	September 2018
Protein Binding	1	2018	2018	September 2018
RNA, Small Interfering	1	2018	2018	September 2018
Tumor Suppressor Protein p53	1	2018	2018	September 2018
Antineoplastic Agents	2	2018	2024	July 2021
Proto-Oncogene Proteins c-mdm2	2	2018	2024	July 2021
Molecular Targeted Therapy	1	2024	2024	April 2024
Neoplasms	1	2024	2024	April 2024

ZHANG's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (24)

Explore

Co-Authors (1)

RUAN, KE-HE

Explore

Similar People (60)

Explore

Same Department

Explore